Baird Medical Showcases Growth Strategy at J.P. Morgan Healthcare Conference
I'm PortAI, I can summarize articles.
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) showcased its growth strategy at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. U.S. CEO Mark Saxton and the leadership team discussed the company's 2026 strategic priorities, emphasizing the expansion of its U.S. commercial presence and promotion of thyroid ablation technologies. This participation highlights Baird Medical's commitment to advancing minimally invasive Microwave Ablation technology.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments